Breast Cancer Clinical Trials in San Francisco

Showing 201-220 of 413 trials

Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

NCT00804128

\*REFERRALS TO THIS TRIAL MUST BE THROUGH BREAST CARE CLINICIANS ONLY\* RATIONALE: Diagnostic procedures, such as contrast-enhanced MRI, may help find and diagnose ductal carcinoma in situ. PURPOSE: This study is to develop and refine magnetic resonance (MR) imaging methods for pre-operative staging of ductal carcinoma in situ, a pre-invasive form of breast cancer, and atypical ductal hyperplasia, a risk factor for developing cancer.

Breast Cancer

University of California, San Francisco76 participantsStarted Oct 2008

San Francisco, California, United States

TERMINATEDPhase 1/2< 1 mile

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

NCT05363605

This first-in-human study evaluates safety, tolerability and distribution of \[225Ac\] FPI-1966, \[111In\]-FPI-1967, and vofatamab in patients with FGFR3-expressing solid tumors.

Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more

Fusion Pharmaceuticals Inc.6 participantsStarted Apr 2022

Duarte, California, United States • San Francisco, California, United States • Iowa City, Iowa, United States +3 more locations

Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Breast Cancer Trials in Other Cities

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Investigation of Novel Surgical Imaging for Tumor Excision

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy

Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer

Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

TAC Versus TC for Adjuvant Breast Cancer

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

Other Conditions in San Francisco